Showing results (181-190 of 282) with videos related to

Sort By:
Pageof 29
Journal of Pharmacology & Pharmacotherapeutics|December 19, 2013
Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reportsCaterina Palleria, Christian Leporini, Serafina Chimirri, et al.
Behavioural Brain Research|January 8, 2017
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effectsCaterina Palleria, Antonio Leo, Francesco Andreozzi, et al.
International Journal of General Medicine|September 30, 2021
Retarding Progression of Chronic Kidney Disease in Autosomal Dominant Polycystic Kidney Disease with Metformin and Other Therapies: An Update of New InsightsNazareno Carullo, Maria Teresa Zicarelli, Alessandro Casarella, et al.
Journal of Clinical Pharmacy and Therapeutics|October 7, 2019
Clinically relevant drug interactions between statins and antidepressantsCaterina Palleria, Roberta Roberti, Luigi Francesco Iannone, et al.
Pharmacological Research|November 24, 2011
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 miceGiovambattista De Sarro, Eugenio Donato Di Paola, Santo Gratteri, et al.
Reviews on Recent Clinical Trials|March 16, 2018
Insulin-Sensiting Effects of Tumor Necrosis Factor Alpha Inhibitors in Rheumatoid Arthritis: A Systematic Review and Meta-AnalysisChristian Leporini, Emilio Russo, Salvatore D Angelo, et al.
Expert Opinion on Drug Safety|April 12, 2017
Adverse drug reactions reporting in Calabria (Southern Italy) in the four-year period 2011-2014: impact of a regional pharmacovigilance project in light of the new European LegislationChristian Leporini, Giuseppina Marrazzo, Laura Mumoli, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 8, 2020
Pharmacokinetic considerations about antiseizure medications in the elderlyRoberta Roberti, Caterina Palleria, Valentina Nesci, et al.
Critical Reviews in Oncology/Hematology|September 18, 2013
Pazopanib a tyrosine kinase inhibitor with strong anti-angiogenetic activity: a new treatment for metastatic soft tissue sarcomaGirolamo Ranieri, Maria Mammì, Eugenio Donato Di Paola, et al.
Plos One|September 23, 2016
Complement C3 Is the Strongest Predictor of Whole-Body Insulin Sensitivity in Psoriatic ArthritisFrancesco Ursini, Salvatore D'Angelo, Emilio Russo, et al.
Pageof 29